Timiperone
 | |
| Clinical data | |
|---|---|
| Trade names | Tolopelon |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | By mouth |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.055.328 |
| Chemical and physical data | |
| Formula | C22H24FN3OS |
| Molar mass | 397.50 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Timiperone, sold under the brand name Tolopelon, is an antipsychotic of the butyrophenone class which is marketed in Japan.[1][2][3] It is similar in chemical structure to benperidol but has a thiourea group instead of a urea group.
References
- ^ Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 1030–. ISBN 978-3-88763-075-1.
- ^ Yamasaki, T; Kojima, H; Tanaka, M; et al. (1981). "Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties". Arzneimittelforschung. 31: 707–15. PMID 6113834.
- ^ "Effect of Timiperone, a New Antipsychotic Drug, on the Sleep-Wakefulness Cycle in Cats". The Japanese Journal of Pharmacology. 39 (3): 391–394. 1985.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |